iifl-logo-icon 1

SMS Lifesciences India Ltd Share Price

1,613.85
(-2.00%)
Sep 13, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,613.85
  • Day's High1,613.85
  • 52 Wk High1,749.65
  • Prev. Close1,646.75
  • Day's Low1,613.85
  • 52 Wk Low 472.05
  • Turnover (lac)2.98
  • P/E25.89
  • Face Value10
  • Book Value607.13
  • EPS62.27
  • Mkt. Cap (Cr.)487.91
  • Div. Yield0
View All Historical Data
No Records Found

SMS Lifesciences India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1,613.85

Prev. Close

1,646.75

Turnover(Lac.)

2.98

Day's High

1,613.85

Day's Low

1,613.85

52 Week's High

1,749.65

52 Week's Low

472.05

Book Value

607.13

Face Value

10

Mkt Cap (₹ Cr.)

487.91

P/E

25.89

EPS

62.27

Divi. Yield

0

SMS Lifesciences India Ltd Corporate Action

6 Aug 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

8 Aug 2023

12:00 AM

AGM

Announcement Date: 08 Aug, 2023

arrow

21 Aug 2023

12:00 AM

BookCloser

arrow

29 May 2023

12:00 AM

Dividend

Dividend Amount: 1.5

arrow

SMS Lifesciences India Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

SMS Lifesciences India Ltd SHAREHOLDING SNAPSHOT

17 Sep, 2024|10:11 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 71.40%

Foreign: 0.00%

Indian: 71.40%

Non-Promoter- 0.01%

Institutions: 0.01%

Non-Institutions: 28.58%

Custodian: 0.00%

Share Price

SMS Lifesciences India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

3.02

3.02

3.02

3.02

Preference Capital

0

0

0

0

Reserves

161

148.19

123.31

110.23

Net Worth

164.02

151.21

126.33

113.25

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

260.25

256.92

344.15

212.98

yoy growth (%)

1.29

-25.34

61.58

-1.34

Raw materials

-139.65

-162.04

-230.28

-132.95

As % of sales

53.66

63.07

66.91

62.42

Employee costs

-27.11

-23.27

-20.63

-17.64

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

19.35

13.33

23.75

6.39

Depreciation

-7.21

-7.24

-5.76

-5.7

Tax paid

-6.18

-4.19

-7.12

0.1

Working capital

6.73

5.63

4.3

1.01

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

1.29

-25.34

61.58

-1.34

Op profit growth

25

-26.72

145.88

-53.6

EBIT growth

29.45

-36.93

176.29

-57.05

Net profit growth

43.95

-45

155.84

-49.77

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

305.96

315.56

349.74

265.59

260.78

Excise Duty

0

0

0

0

0

Net Sales

305.96

315.56

349.74

265.59

260.78

Other Operating Income

0

0

0

0

0

Other Income

3.83

5.42

14.76

1.78

2.28

SMS Lifesciences India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,862.95

160.64,46,984.11237.820.724,409.7498.75

Divis Laboratories Ltd

DIVISLAB

5,479.35

87.571,45,452.894300.552,063507.93

Cipla Ltd

CIPLA

1,659.4

33.751,34,027.851,055.940.783,752.25346.39

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,453.9

77.741,16,844.734690.812,394201.77

Zydus Lifesciences Ltd

ZYDUSLIFE

1,115.85

25.71,12,260.51,700.80.274,035.4156.19

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT SMS Lifesciences India Ltd

Management

Register Office

Registrar Office

Managing Director

T V V S N Murthy

Independent Director

P Sarath Kumar

Company Sec. & Compli. Officer

Trupti Ranjan Mohanty

Executive Director

Talluri Venkata Praveen

Whole-time Director

Sudeepthi Gopin eedi

Independent Director

Mannam Malakondaiah

Independent Director

Srinivas Samavedam

Independent Director

P Venkata Subbarao

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

The Company was incorporated originally as Potluri Real Estate Private Limited on 31May, 2006 for undertaking the activities of real estate business and the Company could not commence business activities andthe companys name has been changed to Potluri Packaging Industries Private Limited on 6 November, 2013. The Company could not undertake any such activities, once again the companys name has been changed to SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company has become a wholly owned subsidiary company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016. Subsequently converted into a Public Company under the Companies Act, 2013 w.e.f. 22 June, 2016.The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad.The Demerger Scheme sanctioned by the National Company Law Tribunal (NCLT) vide its order dated 15-05- 2017 received by the Company on 17-05-2017 has been implemented with appointed date as 01st April, 2016 as provided in the Scheme. Accordingly, the Semi Regulated Facilities i.e., Unit I, IV and V along with (i) premises situated at Industrial Estate, Sanath Nagar, Hyderabad; (ii) Industrial Development area, Jeedimetla, Hyderabad; (iii) Flat No. 417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad and (iv) Vacant Land admeasuring Ac 19.00 situated at Pharma
Read More

Company FAQs

What is the SMS Lifesciences India Ltd share price today?

Down Arrow

The SMS Lifesciences India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1613.85 today.

What is the Market Cap of SMS Lifesciences India Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of SMS Lifesciences India Ltd is ₹487.91 Cr. as of 13 Sep ‘24

What is the PE and PB ratio of SMS Lifesciences India Ltd?

Down Arrow

The PE and PB ratios of SMS Lifesciences India Ltd is 25.89 and 2.77 as of 13 Sep ‘24

What is the 52 Week High and Low of SMS Lifesciences India Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a SMS Lifesciences India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of SMS Lifesciences India Ltd is ₹472.05 and ₹1749.65 as of 13 Sep ‘24

What is the CAGR of SMS Lifesciences India Ltd?

Down Arrow

SMS Lifesciences India Ltd's CAGR for 5 Years at 27.69%, 3 Years at 29.04%, 1 Year at 200.26%, 6 Month at 158.43%, 3 Month at 95.84% and 1 Month at 21.10%.

What is the shareholding pattern of SMS Lifesciences India Ltd?

Down Arrow

The shareholding pattern of SMS Lifesciences India Ltd is as follows:
Promoters - 71.41 %
Institutions - 0.01 %
Public - 28.58 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp